Announcements
- EQUASENS : BILAN SEMESTRIEL S2-2023 DU CONTRAT DE LIQUIDITE
- Equasens: 2023 revenue: €219.7m, +2.6%
- EQUASENS : Chiffre d’affaires 2023 : +2,6 % à 219,7 M€
- EQUASENS : Prise de participation majoritaire dans DIGIPHARMACIE
- Equasens: Acquisition of a majority stake in DIGIPHARMACIE
- EQUASENS : Evolution du Comité de Direction du Groupe Equasens
- Equasens: Changes in the Equasens Group Executive Committee
- EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany
- EQUASENS : Acquisition de l’allemand ADV et naissance de PHARMAGEST Germany
- Equasens: Q3 2023 revenue
More ▼
Key statistics
As of last trade Equasens SA (PHF:FRA) traded at 50.50, 9.43% above its 52-week low of 46.15, set on Feb 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 51.00 |
---|---|
High | 51.00 |
Low | 50.50 |
Bid | 50.80 |
Offer | 51.80 |
Previous close | 51.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 15.17m |
Free float | 5.06m |
P/E (TTM) | 16.11 |
Market cap | 781.47m EUR |
EPS (TTM) | 3.20 EUR |
Annual div (ADY) | 1.15 EUR |
---|---|
Annual div yield (ADY) | 2.25% |
Div ex-date | Jul 03 2023 |
Div pay-date | Jul 05 2023 |
Data delayed at least 15 minutes, as of Mar 28 2024 14:29 BST.
More ▼